NightHawk Biosciences to Present at the 4th Annual Treg Directed Therapies Summit on PTX-35
DURHAM, N.C., May 10, 2022 (GLOBE NEWSWIRE) — NightHawk Biosciences (NYSE American: NHWK), a fully…
News
Agenus Corporate Update and First Quarter 2022 Financial Report
Botensilimab data to be presented and Phase 2 trials to launch. AGEN1571 (ILT2) clinical trials…
Rubius Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
Presented Updated Clinical Data from Monotherapy Phase 1 Arm of RTX-240 Clinical Trial in Advanced…
Eloxx Pharmaceuticals Reports First Quarter 2022 Financial and Operating Results and Provides Business Update
Cystic Fibrosis Foundation (CF Foundation) awarded up to $15.9 million for the ongoing ELX-02 clinical program Topline data from cystic fibrosis (CF) Phase 2…
Ovid Therapeutics Reports First Quarter 2022 Financial Results and Corporate Highlights
Ovid anticipates filing an investigational new drug application (IND) for OV329, a potent GABA aminotransferase…
Science 37® Extends Leadership in Decentralized Clinical Trial Market with NextGen SaaS Release to Fully Orchestrate Decentralized Study Conduct
New release sets the bar as the most comprehensive platform to orchestrate decentralized study conduct—unifying…
NexImmune Announces Appointment of Dr. Leena Gandhi to its Board of Directors
GAITHERSBURG, Md., May 10, 2022 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company…
Acerus Reports First Quarter 2022 Financial Results
TORONTO, May 10, 2022 (GLOBE NEWSWIRE) — Acerus Pharmaceuticals Corporation (“Acerus” or the “Company”) (TSX:…
Corvus Pharmaceuticals Provides Program Updates at R&D Symposium
Highlights new interim data from CPI-818 Phase 1/1b study in patients with relapsed T cell…
Sensei Biotherapeutics Reports First Quarter 2022 Financial Results and Recent Business Highlights
– SNS-101 preclinical data provide encouraging validation of pH-sensitive approach to inhibiting VISTA with high…
Dante Labs receives grant by Italian government to pilot revolutionary CE-IVD, clinical whole genome sequencing-based Citizen Test for a G7 country, starting a new era in clinical genomics
NEW YORK, May 10, 2022 (GLOBE NEWSWIRE) — Dante Labs, a global leader in genomics…
Theratechnologies Initiates Basket Portion of TH1902 First-in-Human Study in Advanced Resistant Malignancies
Phase 1b dose established at 300 mg/m2 or 1.5 times the therapeutic dose of docetaxel…
Inozyme Pharma Reports First Quarter 2022 Financial Results and Provides Business Highlights
– Recently reported positive preliminary biomarker and safety data from ongoing Phase 1/2 clinical trial…
PMV Pharmaceuticals Reports First Quarter 2022 Financial Results and Corporate Highlights
Oral presentation at 2022 ASCO annual meeting to highlight initial data from ongoing Phase 1/2…
Faraday Pharmaceuticals Announces First Patient Enrolled in Phase 3 Trial for Myocardial Infarction
Iocyte AMI-3 Trial to Assess Effectiveness and Safety of FDY-5301 in Improving Outcomes for Anterior…
Cronos Group Reports 2022 First Quarter Results
Consolidated net revenue increased by 99% year-over-year to $25.0 million in Q1 2022 Israel net…
Evaxion Biotech Announces Successful Production of Personalized Cancer Immunotherapies in Phase 1/2a Clinical Trial for EVX-02
COPENHAGEN, Denmark, May 10, 2022 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX), a clinical-stage…
NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer
PRESS RELEASE NMD Pharma appoints Dr. Jorge A. Quiroz as EVP, Chief Medical Officer Dr….
Immatics Initiates Phase 1 Clinical Trial to Evaluate Lead TCR Bispecific IMA401 in Patients with Advanced Solid Tumors
Patient enrollment for IMA401 Phase 1 trial started at first clinical site in Germany The…
COMPASS Pathways plc announces first quarter 2022 financial results and business highlights
LONDON, May 10, 2022 (GLOBE NEWSWIRE) — Highlights: End of phase II meeting held with…